Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 20, 2008 - Issue 1
61
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Pulmonary Inflammation by Ambient Air Particles is Mediated by Superoxide Anion

, &
Pages 11-15 | Received 02 Aug 2007, Accepted 21 Sep 2007, Published online: 06 Oct 2008
 

Abstract

Lung inflammation is a key response to increased levels of particulate air pollution (PM); however, the cellular mechanisms leading to this response remain poorly understood. We have previously shown that oxidants are critical mediators of the inflammatory response elicited by inhalation of ambient air particles. Here we tested the possible role of a specific oxidant, superoxide anion, by using the membrane-permeable analog of superoxide dismutase, Mn(III) tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP). Adult Sprague-Dawley rats were instilled with either urban air particles (UAP) or saline. MnTBAP-treated rats received 10 mg/kg (ip) MnTBAP 2 h prior to exposure to UAP. Recruitment of inflammatory cells into bronchoalveolar lavage was evaluated 4 h after instillation. Rats exposed to UAP showed significant increases in the total cell number (8.9 ± 0.6× 106; sham: 5.1 ± 0.6 × 106, p < .02), the numbers of polymorphonuclear leukocytes (26 ± 4%; sham: 6 ± 1%, p < .0001), protein levels (1.2 ± 0.5 mg/ml, sham:0.4 ± 0.1 mg/ml, p < .001), and a trend of increase in myeloperoxidase levels (5 ± 1; sham: 2 ± 1 mU/ml) in bronchoalveolar lavage (BAL). Pretreatment with MnTBAP at a dose that prevented UAP-induced increases in oxidants effectively prevented increase in BAL cells (2.7 ± 0.6 × 106, p < .0001 vs. UAP), PMN influx into the lungs (4 ± 3%, p < .0001 vs. UAP), and increase in myeloperoxidase (2 ± 1 mU/ml) and protein levels in BAL (0.1 ± 0.1 mg/ml). These data indicate that superoxide anion is a critical mediator of the inflammatory response elicited by PM deposition in the lung.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.